PD34-08 ASSOCIATION BETWEEN DISEASE INDICATION AND STEROID USE AND MINERALOCORTICOID-RELATED TOXICITY OF ABIRATERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATE CANCER: A META-ANALYSIS OF RANDOMIZED CONTROL TRIALS

Authors :: Raj Satkunasivam
Zachary Klaassen
Whitney Padgett
Diana Magee
Amy N. Luckenbaugh
Christopher J.D. Wallis
Aaron A. Laviana
Mary K. Hall
Source :: Journal of Urology. 206
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.
Abstract: INTRODUCTION AND OBJECTIVE:Abiraterone acetate (AA) has proven survival benefit for patients with metastatic hormone sensitive prostate cancer (mHSPC) and metastatic castrate resistant prostate can...

Tools